Concepedia

Publication | Closed Access

Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy

DOI

63

Citations

0

References

2021

Year

Beatriz Sánchez‐Álamo, Amir Shabaka, Victoria Cachofeiro, Clara Cases‐Corona, Gema Fernández‐Juárez
Clinical Nephrology

Abstract

These results suggest that treatment with RAS blockade does not influence IL-6 levels. IL-6 is independently associated with an increased risk for progression of DKD.